3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production

Shing Chuan Shen, Ching Huai Ko, Kuo Chou Hsu, Yen Chou Chen

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Epidermal growth factor (EGF) has been shown to induce proliferation in cells, however, the role of prostaglandin E2 (PGE2) plays in EGF-induced proliferation in still unclear. EGF and PGE2 showed proliferation responses in epidermoid carcinoma cell A431 by MTT and [ 3H] thymidine incorporation assay. Activation of the EGF receptor and extracellular signal-regulated protein kinases (ERK1/2), but not p38 and JNK, appeared 10 min after EGF treatment, whereas total amounts of ERK1/2, p38 and JNK remained unchanged in A431 cells, accompanied by induction of COX-2 and PGE2 production. PD98059, a specific ERK1/2 inhibitor, inhibited EGF-induced proliferation with concomitant decreases in ERK1/2 phosphorylation and COX-2/PGE2 induction. Nonsteroid anti-inflammatory drugs (NSAIDs) such as aspirin and diclofenac, a COX activity inhibitor, inhibited EGF-induced proliferation by blocking PGE2 production. The addition of PGE2 reversed the inhibitory effects of PD98059, aspirin, and diclofenac on EGF-induced proliferation. This suggests that COX-2/PGE 2 activation involves in EGF-induced proliferation and locates at the downstream of ERK 1/2 activation. Furthermore, the natural product, 3-OH flavone, showed the most-potent inhibitory activity on EGF-induced proliferation among 9 structurally-related compounds, and suppression of EGF receptor phosphorylation, ERK1/2 phosphorylation, and COX-2/PGE2 production by 3-OH flavone was identified. PGE2 addition attenuates the inhibitory activity of 3-OH flavone on EGF-induced proliferation by MTT assay and colony formation by soft agar assay. Additionally, 3-OH flavone also showed more-specific inhibition on EGF-than on fetal bovine serum (FBS)-induced proliferation in A431 cells. Results of our present study provide evidence to demonstrate that PGE2 is an important downstream molecule in EGF-induced proliferation, and 3-OH flavone, which inhibits PGE2 production by blocking MAPK cascade, might reserve potential for development as an anti-cancer drug.

Original languageEnglish
Pages (from-to)502-510
Number of pages9
JournalInternational Journal of Cancer
Volume108
Issue number4
DOIs
Publication statusPublished - Feb 4 2004

Fingerprint

flavone
Dinoprostone
Epidermal Growth Factor
Diclofenac
Phosphorylation
Epidermal Growth Factor Receptor
Aspirin

Keywords

  • 3-OH flavone
  • Epidermoid growth factor
  • Extracellular regulatory kinases
  • Mitogen activated protein kinases
  • Proliferation
  • Prostaglandin E

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production. / Shen, Shing Chuan; Ko, Ching Huai; Hsu, Kuo Chou; Chen, Yen Chou.

In: International Journal of Cancer, Vol. 108, No. 4, 04.02.2004, p. 502-510.

Research output: Contribution to journalArticle

@article{0de4842b70584798811ac2b3cd41783a,
title = "3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production",
abstract = "Epidermal growth factor (EGF) has been shown to induce proliferation in cells, however, the role of prostaglandin E2 (PGE2) plays in EGF-induced proliferation in still unclear. EGF and PGE2 showed proliferation responses in epidermoid carcinoma cell A431 by MTT and [ 3H] thymidine incorporation assay. Activation of the EGF receptor and extracellular signal-regulated protein kinases (ERK1/2), but not p38 and JNK, appeared 10 min after EGF treatment, whereas total amounts of ERK1/2, p38 and JNK remained unchanged in A431 cells, accompanied by induction of COX-2 and PGE2 production. PD98059, a specific ERK1/2 inhibitor, inhibited EGF-induced proliferation with concomitant decreases in ERK1/2 phosphorylation and COX-2/PGE2 induction. Nonsteroid anti-inflammatory drugs (NSAIDs) such as aspirin and diclofenac, a COX activity inhibitor, inhibited EGF-induced proliferation by blocking PGE2 production. The addition of PGE2 reversed the inhibitory effects of PD98059, aspirin, and diclofenac on EGF-induced proliferation. This suggests that COX-2/PGE 2 activation involves in EGF-induced proliferation and locates at the downstream of ERK 1/2 activation. Furthermore, the natural product, 3-OH flavone, showed the most-potent inhibitory activity on EGF-induced proliferation among 9 structurally-related compounds, and suppression of EGF receptor phosphorylation, ERK1/2 phosphorylation, and COX-2/PGE2 production by 3-OH flavone was identified. PGE2 addition attenuates the inhibitory activity of 3-OH flavone on EGF-induced proliferation by MTT assay and colony formation by soft agar assay. Additionally, 3-OH flavone also showed more-specific inhibition on EGF-than on fetal bovine serum (FBS)-induced proliferation in A431 cells. Results of our present study provide evidence to demonstrate that PGE2 is an important downstream molecule in EGF-induced proliferation, and 3-OH flavone, which inhibits PGE2 production by blocking MAPK cascade, might reserve potential for development as an anti-cancer drug.",
keywords = "3-OH flavone, Epidermoid growth factor, Extracellular regulatory kinases, Mitogen activated protein kinases, Proliferation, Prostaglandin E",
author = "Shen, {Shing Chuan} and Ko, {Ching Huai} and Hsu, {Kuo Chou} and Chen, {Yen Chou}",
year = "2004",
month = "2",
day = "4",
doi = "10.1002/ijc.11581",
language = "English",
volume = "108",
pages = "502--510",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production

AU - Shen, Shing Chuan

AU - Ko, Ching Huai

AU - Hsu, Kuo Chou

AU - Chen, Yen Chou

PY - 2004/2/4

Y1 - 2004/2/4

N2 - Epidermal growth factor (EGF) has been shown to induce proliferation in cells, however, the role of prostaglandin E2 (PGE2) plays in EGF-induced proliferation in still unclear. EGF and PGE2 showed proliferation responses in epidermoid carcinoma cell A431 by MTT and [ 3H] thymidine incorporation assay. Activation of the EGF receptor and extracellular signal-regulated protein kinases (ERK1/2), but not p38 and JNK, appeared 10 min after EGF treatment, whereas total amounts of ERK1/2, p38 and JNK remained unchanged in A431 cells, accompanied by induction of COX-2 and PGE2 production. PD98059, a specific ERK1/2 inhibitor, inhibited EGF-induced proliferation with concomitant decreases in ERK1/2 phosphorylation and COX-2/PGE2 induction. Nonsteroid anti-inflammatory drugs (NSAIDs) such as aspirin and diclofenac, a COX activity inhibitor, inhibited EGF-induced proliferation by blocking PGE2 production. The addition of PGE2 reversed the inhibitory effects of PD98059, aspirin, and diclofenac on EGF-induced proliferation. This suggests that COX-2/PGE 2 activation involves in EGF-induced proliferation and locates at the downstream of ERK 1/2 activation. Furthermore, the natural product, 3-OH flavone, showed the most-potent inhibitory activity on EGF-induced proliferation among 9 structurally-related compounds, and suppression of EGF receptor phosphorylation, ERK1/2 phosphorylation, and COX-2/PGE2 production by 3-OH flavone was identified. PGE2 addition attenuates the inhibitory activity of 3-OH flavone on EGF-induced proliferation by MTT assay and colony formation by soft agar assay. Additionally, 3-OH flavone also showed more-specific inhibition on EGF-than on fetal bovine serum (FBS)-induced proliferation in A431 cells. Results of our present study provide evidence to demonstrate that PGE2 is an important downstream molecule in EGF-induced proliferation, and 3-OH flavone, which inhibits PGE2 production by blocking MAPK cascade, might reserve potential for development as an anti-cancer drug.

AB - Epidermal growth factor (EGF) has been shown to induce proliferation in cells, however, the role of prostaglandin E2 (PGE2) plays in EGF-induced proliferation in still unclear. EGF and PGE2 showed proliferation responses in epidermoid carcinoma cell A431 by MTT and [ 3H] thymidine incorporation assay. Activation of the EGF receptor and extracellular signal-regulated protein kinases (ERK1/2), but not p38 and JNK, appeared 10 min after EGF treatment, whereas total amounts of ERK1/2, p38 and JNK remained unchanged in A431 cells, accompanied by induction of COX-2 and PGE2 production. PD98059, a specific ERK1/2 inhibitor, inhibited EGF-induced proliferation with concomitant decreases in ERK1/2 phosphorylation and COX-2/PGE2 induction. Nonsteroid anti-inflammatory drugs (NSAIDs) such as aspirin and diclofenac, a COX activity inhibitor, inhibited EGF-induced proliferation by blocking PGE2 production. The addition of PGE2 reversed the inhibitory effects of PD98059, aspirin, and diclofenac on EGF-induced proliferation. This suggests that COX-2/PGE 2 activation involves in EGF-induced proliferation and locates at the downstream of ERK 1/2 activation. Furthermore, the natural product, 3-OH flavone, showed the most-potent inhibitory activity on EGF-induced proliferation among 9 structurally-related compounds, and suppression of EGF receptor phosphorylation, ERK1/2 phosphorylation, and COX-2/PGE2 production by 3-OH flavone was identified. PGE2 addition attenuates the inhibitory activity of 3-OH flavone on EGF-induced proliferation by MTT assay and colony formation by soft agar assay. Additionally, 3-OH flavone also showed more-specific inhibition on EGF-than on fetal bovine serum (FBS)-induced proliferation in A431 cells. Results of our present study provide evidence to demonstrate that PGE2 is an important downstream molecule in EGF-induced proliferation, and 3-OH flavone, which inhibits PGE2 production by blocking MAPK cascade, might reserve potential for development as an anti-cancer drug.

KW - 3-OH flavone

KW - Epidermoid growth factor

KW - Extracellular regulatory kinases

KW - Mitogen activated protein kinases

KW - Proliferation

KW - Prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=0346157021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346157021&partnerID=8YFLogxK

U2 - 10.1002/ijc.11581

DO - 10.1002/ijc.11581

M3 - Article

C2 - 14696113

AN - SCOPUS:0346157021

VL - 108

SP - 502

EP - 510

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -